Aprea Therapeutics
APRE
#10449
Rank
A$15.2 M
Marketcap
A$1.33
Share price
4.70%
Change (1 day)
-45.14%
Change (1 year)

Market capitalization of Aprea Therapeutics (APRE)

Market cap: A$15.2 Million

As of April 2026 Aprea Therapeutics has a market cap of A$15.2 Million. This makes Aprea Therapeutics the world's 10449th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Aprea Therapeutics from 2019 to 2026

End of year Market Cap

Year Marketcap Change
2026A$15.2 M48.52%
2025A$10.23 M-65.24%
2024A$29.44 M14.23%
2023A$25.77 M-0%
2022A$25.77 M-69.66%
2021A$84.97 M-37.32%
2020A$0.13 B-90.15%
2019A$1.37 B

End of Day market cap according to different sources

On Apr 22nd, 2026 the market cap of Aprea Therapeutics was reported to be:

A$16.43 Million
by Nasdaq info icon info icon
A$15.2 Million
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Magellan Health
MGLN
A$3.49 B 22,892.54%๐Ÿ‡บ๐Ÿ‡ธ USA
Amedisys
AMED
A$4.64 B 30,430.61%๐Ÿ‡บ๐Ÿ‡ธ USA
Healthcare Services Group
HCSG
A$2.24 B 14,685.10%๐Ÿ‡บ๐Ÿ‡ธ USA